التفاصيل البيبلوغرافية
| العنوان: |
Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study) |
| المؤلفون: |
Masashi Shimoda, Yukino Katakura, Akiko Mashiko, Masahiro Iwamoto, Shuhei Nakanishi, Takatoshi Anno, Fumiko Kawasaki, Atsushi Obata, Yoshiro Fushimi, Junpei Sanada, Kenji Kohara, Hayato Isobe, Yuichiro Iwamoto, Hidenori Hirukawa, Fuminori Tatsumi, Yukiko Kimura, Tomohiko Kimura, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto |
| المصدر: |
Frontiers in Endocrinology, Vol 15 (2024) |
| بيانات النشر: |
Frontiers Media S.A., 2024. |
| سنة النشر: |
2024 |
| المجموعة: |
LCC:Diseases of the endocrine glands. Clinical endocrinology |
| مصطلحات موضوعية: |
β-cell function, DPP-4 inhibitor, proinsulin, SGLT2 inhibitor, type 2 diabetes, Diseases of the endocrine glands. Clinical endocrinology, RC648-665 |
| الوصف: |
AimsThe aim of this study is to directly compare the effects of SGLT2 inhibitors and DPP-4 inhibitors on β-cell function in patients with type 2 diabetes.Materials and methodsWe conducted a 26-week, randomized, open-label, parallel-group study, including a 1-2 week drug washout period, in patients with type 2 diabetes with HbA1c ≥7.0% and |
| نوع الوثيقة: |
article |
| وصف الملف: |
electronic resource |
| اللغة: |
English |
| تدمد: |
1664-2392 |
| Relation: |
https://www.frontiersin.org/articles/10.3389/fendo.2024.1412553/full; https://doaj.org/toc/1664-2392 |
| DOI: |
10.3389/fendo.2024.1412553 |
| URL الوصول: |
https://doaj.org/article/214b5df748a049da953de0bc203a615c |
| رقم الانضمام: |
edsdoj.214b5df748a049da953de0bc203a615c |
| قاعدة البيانات: |
Directory of Open Access Journals |
Full Text Finder